// App-Quantinova.ai

1077 : Harmony Alliance Provides Novel Insights into Acute Myeloid Leukemia Based on a Pan-European NGS Data Collection

Researchers

Presenter

  • Lars Bullinger

Principal Investigators

  • Eric Strng

  • Castellani Gastone

  • Caroline A Heckman

  • Ana Heredia Casanoves

  • Jurjen Versluis

  • Moritz Gerstung

  • Mara Abigar

  • Alberto Hernandez-Sanchez

  • Laura Jamilis

  • Ral Azibeiro Melchor

  • Peter JM Valk

  • Klaus H. Metzeler

  • Rosa Ayala

  • Joaquin Martinez Lopez

  • Herv Dombret

  • Pau Montesinos

  • Jorge Sierra

  • Claude Preudomme

  • Frederik Damm

  • Ken I Mills

  • Jiri Mayer

  • Christian Thiede

  • Maria Teresa Voso

  • Sergio Amadori

  • Guillermo F Sanz

  • Frederico Calado

  • Konstanze Dohner

  • Verena I Gaidzik

  • Michael Heuser

  • Torsten Haferlach

  • Marta Sobas

  • Amin T. Turki

  • Dirk Reinhardt

  • Rubn Villoria Medina

  • Michel van Speybroeck

  • Renate Schulze-Rath

  • Jess M Hernndez Rivas

  • Brian J. P. Huntly

  • Hartmut Dhner

  • Gert J. Ossenkoppele

Medical Centers

  • Department of Hematology, Oncology and Tumor Immunology, Charite University Medicine, Campus Benjamin Franklin, Berlin, Germany

  • Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain

  • Department of Hematology, Oncology and Tumor Immunology, Charite University Medicine, Campus Benjamin Franklin, Berlin, Germany

  • Univeristy of Bologna, Bologna, Italy

  • Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.

  • GMV Innovating Solutions, Valencia, Spain

  • Erasmus University Medical Center Cancer Institute, Rotterdam, Rotterdam, Netherlands

  • European Bioinformatics Institute, Cambridge, United Kingdom

  • Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

  • Department of Medicine III, University Hospital Grosshadern/LMU, Munich, Germany

  • Hematology Department, Hospital Universitario La Princesa, Madrid, Spain

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • Division of Hematology, EA3518 Saint-Louis Institute for Research, Hôpital Saint-Louis, APHP, University of Paris, Paris, France, Paris, France

  • Hematology Department, Hospital Universitario La Fe de Valencia,, Valencia, Spain, Spain

  • Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  • University Hospital of Lille, Lille, France

  • Oncology and Tumor Immunology, Charite - Universitaetsmedizin Berlin, Berlin, Germany

  • Patrick G. Johnston Centre for Cancer Research,Queen's University Belfast,Belfast,United Kingdom

  • University Hospital Brno, Czech Republic, Brno, CZE

  • Dept. of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany

  • Dipartimento di Biopatologia e Diagnostica per Immagini, University of Rome Tor Vergata, Rome, Italy

  • Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy

  • Rheumatology Department, Hospital Universitari i Politecnic la Fe, Valencia, Spain

  • Novartis, Oncology Region Europe,Basel,Suíça

  • Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany

  • Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

  • MLL Muenchner Leukaemie Labor, Muenchen, Germany

  • Department of Hematology, Wroclaw Medical University, Wroclaw, Poland

  • Department of Bone Marrow Transplantation, University Hospital Essen, West German Cancer Center, Essen, Germany

  • Department of Pediatric Oncology and Hematology, Essen University Hospital, Essen, Germany

  • Data Science, Janssen Pharmaceutica N.V., Beerse, Belgium

  • Bayer Pharma AG, Berlin, Germany

  • Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  • Department of Hematology, Amsterdam UMC, Vrije Universiteit Cancer Center, Amsterdam, Netherlands

Locations

  • Germany

  • Spain

  • Italy

  • Finland

  • Netherlands

  • United Kingdom

  • France

  • Switzerland

  • Poland

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved